Manufacturers report positive interim data with REGEN-COV antibody cocktail used as passive vaccine to prevent COVID-19

Initial results from a phase III study found that casirivimab and imdevimab, used as a passive vaccine for the prevention of COVID-19 in people with household exposure to a COVID-19 patient, reduced the rate of infection by 50% vs placebo.

Source:

Biospace Inc.